FAAH inhibitors
FAAH (fatty acid amide hydrolase) inhibitors are pharmaceutical agents designed to block the action of FAAH, an enzyme responsible for breaking down endocannabinoids such as anandamide and related fatty acid amides. By inhibiting FAAH, these compounds increase the levels of endocannabinoids in the body, which in turn activate cannabinoid receptors like CB1 and CB2. This modulation of the endocannabinoid system has potential therapeutic implications in various conditions including pain management, inflammation, anxiety, and neurodegenerative disorders. FAAH inhibitors are being studied for their role in enhancing the body's natural pain-relieving and anti-inflammatory responses without directly activating cannabinoid receptors in the same way as exogenous cannabinoids like THC.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:3 Page 1 of 1 1
![N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide](http://file1.lookchem.com/300w/substances/2022-02-14-06/18a7e2a9-a4d4-40fc-8a2f-384b46ea3a16.png)
